US 11439709
Phospholipid ether analogs as cancer-targeting drug vehicles
granted A61KA61K31/00A61K31/337
Quick answer
US patent 11439709 (Phospholipid ether analogs as cancer-targeting drug vehicles) held by CELLECTAR BIOSCIENCES, INC. expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CELLECTAR BIOSCIENCES, INC.
- Grant date
- Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/00, A61K31/337, A61K31/395, A61K31/537